Colchicine Market - Forecast(2023 - 2028)

Report Code: CMR 0991 Report Format: PDF + Excel

Colchicine Market Overview:

Colchicine is a drug used to treat gout disease and available as colcry, mitigare, zyclochin and so on brand names. It function is not to cure gout disease rather it prevents causing gout attacks. Also it is not an ordinary pain reliever and it can be used daily under doctor’s prescription. It is available in different forms. FDA government put a ban on Colchicine drug. U.S are the largest markets in colchicine market. 

Colchicine Market Outlook:

Colchicine is an anti-gout, anti-inflammatory drug using from several years onwards. Its function is to lessen the uric acid in blood. It is available as different forms like tablets, capsules, ointment and so on. Preventing gout disease is primary function of colchicine drug. FMF (Familial Mediterranean fever) disease is also using this drug. The applications industries of this drug are chemical, pharmaceutical, agricultural and so on. 

Colchicine market report comprises of pricing analysis for different brands of colchicine available in the market. The average price of generic brand colchicine for o.6mg is around $180 to $202. The brand name colcrys has average price of $181-$264 and Mitigare has $192 to $229.  Different generic colchicine tablets varies from 10-30 rupees for 10 tablets of 0.5 mg. 

Colchicine Market Growth Drivers: 

Geriatrics are suffered from gout attack. They prefer colchicine drug on daily basis. This is one of the driving force in the market that increases market growth. Daily consumption for curing FMF in adults and child 4 years old became driving force in this market. 

Colchicine Market Challenges: 

The price fluctuations of colchicine drug is a challenge in this market. After 2009, cost of this drug suddenly increases to $0.10 to $5. Researches are finding to reduce the cost of the drug comparing with generic colchicine drug. 

Colchicine Market Research Scope:

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the colchicine. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of colchicine market, and their specific applications in different types of vehicles.

Colchicine Market Report: Industry Coverage:

Form of Colchicine Drug: Tablets, injection, capsule, ointment, cream. 
Applications of colchicine Drug: Gout diseases, Amyloidosis, Behcet's disease, Dermatitis herpetiformis, Familial Mediterranean fever (FMF), Paget's disease, Pericarditis, Pseudogout, Biliary and hepatic cirrhosis. 
End Users of colchicine Drug: Humans, Cows, Rats, Dogs, Others.

The colchicine market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:
  • North America: The U.S., Canada, Mexico
  • South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
  • Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
  • APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
  • Middle East and Africa: Israel, South Africa, Saudi Arabia

Colchicine Market Key Players Perspective:

Douglas cole, president of Tadeka Pharmaceuticals U.S.A has shared his view on colchicine genic name and colcrys brand name. Their company Takeda made partnership with prasco laboratories and Westward companies and allow prasco Company to manufacture colcrys drug as same standard as colchicine drug to serve gout patients. 
Some of the other key players mentioned in this report are pubchem,, Himka, prasco, westward, cipla, Takeda Pharmaceuticals U.S.A., Hikma Pharmaceuticals PLC, Wockhard and few more companies. 

Colchicine Market Trends:

  • On October 2010, the Food and Drug Administrative (FDA) Department has stopped the single oriented oral colchicine drug pretending that have no safety measures and also fatal to the users. It also ordered the government not to sell in the market and action is taken on them.  
  • URL company acquired by Tadeka Pharmaceutical company has access to sell the branded name of colchicine as colcrys in the market with $ 5 per pill. Also Tadeka company made an agreement with Par international company to sell their colcrys product brand. 
For more Chemical and Materials related reports, please click here
1. Colchicine Market- Overview
1.1. Definitions and Scope
2. Colchicine Market- Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Colchicine Market
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Colchicine Market– Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Colchicine Market– Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Colchicine Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Colchicine Market-Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
8. Colchicine Market– By Application Type (Market Size -$Million / $Billion)
8.1. Segment type Size and Market Share Analysis 
8.2. Application Revenue and Trends by type of Application
8.3. Application Segment Analysis by Type
8.3.1. Agriculture
8.3.2. Gout diseases 
8.3.3. Amyloidosis
8.3.4. Behcet's disease
8.3.5. Dermatitis herpetiformis
8.3.6. Familial Mediterranean fever (FMF)
8.3.7. Paget's disease
8.3.8. Pericarditis
8.3.9. Pseudogout
8.3.10. Biliary and hepatic cirrhosis. 
8.3.11. Others 
9. Colchicine Market – Type of Category 2 (Market Size -$Million / $Billion)
9.1. Tablets
9.2. Capsule
9.3. Injection
9.4. Cream
9.5. Gel
9.6. Syrup
9.7. Ointment 
9.8. Ointment 
10. Colchicine Market- By Geography (Market Size -$Million / $Billion)
10.1. Colchicine Market- North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size U.S. Canada Mexico Rest of North America
10.3. Colchicine Market- South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size Brazil Venezuela Argentina Ecuador Peru Colombia Costa Rica Rest of South America
10.5. Colchicine Market- Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size U.K Germany Italy France Netherlands Belgium Spain Denmark Rest of Europe
10.7. Colchicine Market– APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size China Australia Japan South Korea India Taiwan Malaysia Hong Kong Rest of APAC
10.9. Colchicine Market– Middle East Segment and Africa Segment Research
10.10. Middle East & Africa Market Research (Market Size -$Million / $Billion)
10.10.1. Segment type Size and Market Size Analysis 
10.10.2. Revenue and Trend Analysis
10.10.3. Application Revenue and Trends by type of Application 
10.10.4. Company Revenue and Product Analysis
10.10.5. Middle East Segment Product type and Application Market Size Israel Saudi Arabia UAE
10.10.6. Africa Segment Analysis South Africa Rest of Middle East & Africa
11. Colchicine Market- Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Colchicine Market– Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practices for companies
13. Colchicine Market– Key Company List by Country Premium
14. Colchicine Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Himka
14.3. Prasco
14.4. Westward
14.5. Cipla
14.6. Takeda Pharmaceuticals U.S.A.
14.7. Hikma Pharmaceuticals PLC
14.8. Wockhard
14.9. Company8
14.10. Compan9
14.11. Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Colchicine Market-Appendix
15.1. Abbreviations
15.2. Sources
16. Colchicine Market-Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends